Evidence map›Paper›PMID 42188781›Full record

ReviewVaccines2026

Modern Strategies for Brucellosis Vaccination: From Traditional Approaches to Innovative Platforms.

Nurika Assanzhanova, Kuandyk Zhugunissov, Olga Chervyakova, Sholpan Ryskeldinova, Nurlan Akmyrzayev, Aigerim Sagymbayeva, Yeldos Myrzakhmetov, Aigerim Mailybayeva

Abstract readReview
In one paragraph

Review in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nurika AssanzhanovaResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-7267-3931
Kuandyk ZhugunissovResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0003-4238-5116
Olga ChervyakovaResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-7954-6246
Sholpan RyskeldinovaResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.
Nurlan AkmyrzayevResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-8896-3482
Aigerim SagymbayevaResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-5938-3454
Yeldos MyrzakhmetovResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0003-0627-0442
Aigerim MailybayevaResearch Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-4722-0495

Funding

Research Institute for Biological Safety Problems. BR25293294
6 · The paper itself

Abstract

Brucellosis remains one of the most widespread zoonotic infections worldwide, causing serious veterinary, medical, and socio-economic consequences. The disease, caused by bacteria of the genus

Indexed as

BrucellaBrucella abortusBrucella melitensisDIVADNA vaccineshuman vaccinesOne Healthsubunit vaccinesvaccinesvector vaccines

Identifiers

PMID42188781
PMCPMC13211462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.